Global Life Sciences Update
Switzerland to Become First World Health Organization BioHub
September 28, 2021
お知らせ
Spiez, a quaint small town close to the Bernese Alps in Switzerland, will host the first World Health Organization BioHub facility. The objective of this initiative is the safe receipt, storage, and distribution of pathogens to laboratories worldwide to make the fight against them more efficient.
On May 24, 2021, in his speech at the 74th World Health Assembly in Geneva, Swiss Health Minister Alain Berset called for “close international collaboration to ensure the timely sharing of epidemiological and clinical data as well as biological materials.”
One step in that direction was taken on the same day, when Berset and WHO Director-General Tedros Adhanom Ghebreyesus signed a memorandum of understanding (MoU) between the WHO and Switzerland by which the WHO took Switzerland up on its offer to provide space and knowledge for a global pathogen exchange. According to the MoU, Switzerland will make available its Biocontainment Laboratory in Spiez as WHO’s first BioHub.
Currently, most pathogen sharing is done bilaterally between countries and on an ad hoc basis, which can be slow and can leave some countries without access to the benefits and tools. The BioHub is set up to change this and to allow WHO member states to share biological materials with and via the facility, which will serve as a center for the safe receipt, sequencing, storage, and preparation of pathogens for distribution to other laboratories. The objective is to inform risk assessments and sustain global preparedness against pathogens, like the SARS-CoV-2 virus, which may cause an epidemic or even a pandemic.
The BioHub facility is part of WHO’s broader BioHub system for the use of biological materials, which is not limited to state laboratories but also open to other qualified entities such as manufacturers.
One step in that direction was taken on the same day, when Berset and WHO Director-General Tedros Adhanom Ghebreyesus signed a memorandum of understanding (MoU) between the WHO and Switzerland by which the WHO took Switzerland up on its offer to provide space and knowledge for a global pathogen exchange. According to the MoU, Switzerland will make available its Biocontainment Laboratory in Spiez as WHO’s first BioHub.
Currently, most pathogen sharing is done bilaterally between countries and on an ad hoc basis, which can be slow and can leave some countries without access to the benefits and tools. The BioHub is set up to change this and to allow WHO member states to share biological materials with and via the facility, which will serve as a center for the safe receipt, sequencing, storage, and preparation of pathogens for distribution to other laboratories. The objective is to inform risk assessments and sustain global preparedness against pathogens, like the SARS-CoV-2 virus, which may cause an epidemic or even a pandemic.
The BioHub facility is part of WHO’s broader BioHub system for the use of biological materials, which is not limited to state laboratories but also open to other qualified entities such as manufacturers.
Sidley Austin LLPはクライアントおよびその他関係者へのサービスの一環として本情報を教育上の目的に限定して提供します。本情報をリーガルアドバイスとして解釈または依拠したり、弁護士・顧客間の関係を結ぶために使用することはできません。
弁護士広告 - ニューヨーク州弁護士会規則の遵守のための当法律事務所の本店所在地は、Sidley Austin LLP ニューヨーク:787 Seventh Avenue, New York, NY 10019 (+212 839 5300)、シカゴ:One South Dearborn, Chicago, IL 60603、(+312 853 7000)、ワシントン:1501 K Street, N.W., Washington, D.C. 20005 (+202 736 8000)です。
オフィス
最新情報はこちらから